Home » Topics » Conferences

Conferences
RSS

GI-5005 plus pegIFNalpha-2a/RBV shows clinical potential in chronic HCV patients

May 4, 2010

Covalent irreversible HCV NS3 protease inhibitors disclosed by Avila Therapeutics

May 4, 2010

Phase I/II results reported for GMI-1070 in sickle cell disease

May 4, 2010

Four-year COMBAT data detail benefits of Duodart in benign prostatic hyperplasia

May 4, 2010

Palmitoylethanolamide enhances efficacy of topical ocular antihypertensive treatments

May 3, 2010

Phase III Trinity study results reported for olmesartan/amlodipine/HCTZ in hypertension

May 3, 2010

Cleveland Biolabs describes novel curaxin radiosensitizers for cancer

May 3, 2010

LigoCyte updates norovirus vaccine clinical development progress

May 3, 2010

Polo-like kinase 1 inhibitors from Cyclacel active in xenograft cancer models

May 3, 2010

IMPACT-DCM results encourage larger trials of cardiac repair cells in dilated cardiomyopathy

May 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...